XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Deferred financing costs $ 12,746 $ 17,190
Deferred financing costs $ 7,565 $ 7,277
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 6,770,393 6,770,393
Preferred stock, shares outstanding (in shares) 6,770,393 6,770,393
Preferred stock, liquidation preference $ 169,260 $ 169,260
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 143,288,347 153,537,296
Common stock, shares outstanding (in shares) 143,288,347 153,537,296
CECL allowance $ 236,207 $ 39,276
Loan specific reserves 196,931 56,981
General CECL allowance related to unfunded commitments 3,595 0
Commercial Mortgage Portfolio Segment    
Loans pledged as collateral $ 5,405,220 $ 4,852,087